Detalhe da pesquisa
1.
Performance of IPSS-M in patients with myelodysplastic syndrome after hypomethylating agent failure.
Am J Hematol
; 98(10): E281-E284, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37515433
2.
Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm.
Blood Adv
; 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513082
3.
Characteristics of patients with myelodysplastic neoplasm and spliceosome mutations.
Leukemia
; 37(6): 1397-1400, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37185307